Food waste is a global problem with approximately 1.3 billion tonnes of food wasted each year throughout the food lifecycle – from the farm to food manufacturers and households.
Across the food supply chain, Australians waste around 7.6 million tonnes of food each year. This costs our economy approximately A$36.6 billion annually.
In a recent study published in Bioresource Technology Reports, we have found a way to use food waste for making a versatile material known as nanocellulose. In particular, we used acid whey – a significant dairy production waste material that it usually difficult to dispose of.
Mixing waste with bacteria
Nanocellulose is a biopolymer, which means it’s a naturally produced long chain of sugars. It has remarkable properties – bacterial nanocellulose is strong, chemically stable and biocompatible, meaning it’s not harmful to human cells. This makes it a highly marketable product with applications in packaging, wound treatments, drug delivery or food production.
The traditional approach for making nanocellulose can be expensive, uses large amounts of energy and takes a long time. Some types of nanocellulose production also use a chemical process that produces unwanted waste byproducts.
By contrast, our new approach uses just food waste and a symbiotic culture of bacteria and yeasts (SCOBY) – something you may be familiar with as a kombucha starter. Our process is low cost, consumes little energy and produces no waste.
We used a runny waste liquid known as acid whey from a local cheese manufacturer in Melbourne, Australia. In the dairy industry, acid whey is often disposed of as wastewater in large amounts (more than 100 million litres of acid whey are produced annually in Australia alone), despite it being rich in carbohydrates and proteins. This is because it’s hard to process into other products due to a high lactic acid content.
We heat-treated the liquid and supplemented it with sugar and yeast extract before adding the key ingredient, SCOBY (obtained commercially from a Melbourne-based kombucha company).
Over four days as our mixture fermented, the bacteria worked to create nanocellulose material which floated to the top. Lovers of home-brewed kombucha may actually be familiar with the raw nanocellulose material – it forms as a floating off-white structure called a pellicle. Some people already use this kombucha by-product as vegan leather.) A similar pellicle formed on our acid whey mixture.
The pellicle - the white stuff that grows on top of a homemade kombucha brew - is actually a type of nanocellulose. Shutterstock
A growing market
Demand for nanocellulose is growing worldwide. The global market was valued at US$0.4 billion in 2022 (A$0.6bn) and is expected to grow to US$2 billion by 2030 (A$3.1bn). Bacterial nanocellulose produced from food waste can help to satisfy this demand.
This growth is in part due to how we can use nanocellulose instead of petroleum-based and other non-renewable materials in things like packaging. Among its desirable properties, nanocellulose is also fully biodegradable.
Manufacturers around the globe are seeking sustainable sources of raw material for producing composite materials with various properties. Nanocellulose is easily customised in this way. For example, infusing nanocellulose with a compound called glycerol enhances its flexibility and makes it more pliant. As a food-safe material, we are now investigating nanocellulose as “smart” packaging by infusing nanocellulose with indicators that signal when food is no longer safe to eat.
Additionally, using a single source of food waste (such as acid whey in our example) means we can produce highly pure nanocellulose – ideal for biomedical applications, such as wound dressings, pharmaceutical compounding and cell cultures.
An example of nanocellulose material that could be used for wound dressing. Shutterstock
Efficient circular economy
A circular economy attempts to minimise waste and extend the lifecycle of products for as long as possible. Our study demonstrates an efficient circular economy approach for upcycling a dairy industry waste product into sustainable nanocellulose.
Additionally, the sediment residue we produced has a high nutrient value and potentially has commercial value as a fertiliser or animal feed, while the liquid culture can be reused for the next batch.
Our study was limited to a single source of food waste within a laboratory environment. A future challenge will be taking this approach out of the lab and scaling it up for commercial use. This will involve a series of steps throughout the value chain from waste collection and transport through to commercial production.
We also hope to explore alternative mediums such as mixed food waste. More research also needs to be done on how nanocellulose can be most effectively customised for various applications, such as different types of food packaging.
Overall, our proof-of-concept study demonstrates potential for producing nanocellulose in a sustainable, environmentally sound manner – from food waste to significant value.


Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Neuralink Expands Brain Implant Trials with 12 Global Patients
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy 





